Global Apheresis Market Research Report
- Report Code: AP 1000
- Publish Date: Upcoming
Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. This process involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. The global apheresis market was valued at $1,328.81 million in 2013 and is expected to reach $2,240.09 million by 2018, at a CAGR of 8.5% from 2013 to 2018. The application of therapeutic apheresis for pediatric treatment is an unexplored market and represents a prospective opportunity in the future.
The report analyzes the segmentation of the apheresis market in terms of procedure, application, technology, product type, and end-users. In terms of procedure, the segments of the market are donor apheresis and therapeutic apheresis (neurologic disorders, blood disorders, TTP, and leukemia, among others), renal disease, and metabolic disorders, among others such as rheumatic disorders, malaria, and hyperviscosity syndrome. On the basis of application, the market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukoreduction/leukapheresis, photopheresis, lipidpheresis, and immunoadsoption. In terms of technology, the market is segmented into centrifugation and membrane separation/filtration. In terms of product type, devices and disposables constitute the overall market. In term of end-users, blood banks/blood collection centers, and hospitals & attached blood banks, among others form the overall market.
This market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation, and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.
North America held the largest market share of 50% in the global market, followed by Europe, in 2012. In the next five years, emerging countries are estimated to register the fastest growth rate, primarily due to increasing investments and huge demand for blood components from highly populated countries such as China and India.
The disposables segment is leading the apheresis market accounted for $1,176.72 million in 2013 and is expected to reach $2,131.30 million by 2018, at a CAGR of 11.3% from 2013 to 2018. The disposables segment accounted for the largest share of 88.55% in the overall apheresis market in 2013. The apheresis device market is expected to grow at a CAGR of 8.5% from 2013 to 2018, to reach a value of $229.90 million by 2018.
Portable devices and advancements in technology, along with higher growth opportunities from the Asian countries, are expected to drive this market in the coming years. Increasing apheresis procedures and plasma collection is expected to drive the apheresis disposables market in the coming years.
The report also provides an extensive competitive landscaping of the leading companies operating in the apheresis market. The key players in the market include Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), among others. Furthermore, segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of Alzheimer’s, Parkinson’s, leukemia, kidney stone, malaria, rheumatoid arthritis
- Country-specific patient pool of Alzheimer’s, Parkinson’s, leukemia, kidney stone, malaria, rheumatoid arthritis
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of direct nerve repair, nerve grafting, stem cell therapy, neurostimulation/neuromodulation, and kidney stone procedures performed in each country
Surgeons’/ Physicians’ Perception analysis
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Pattern analysis of usage of donor apheresis and therapeutic apheresis by physicians
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the vitality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of donor apheresis and therapeutic apheresis in the region
Competitive Intelligence
- The company share analysis of the apheresis market top players in the region
- The crucial developments and strategies of companies inculcating in their portfolio for the apheresis market
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Donor Apheresis Donor Apheresis and Therapeutic Apheresis adds up to total |
Upcoming |
|
|
Therapeutic Apheresis Therapeutic Apheresis and Donor Apheresis adds up to total Apheresis... |
Upcoming |
|
|
Apheresis Devices The market for global apheresis devices was pegged at $1.347 billion in 2013 and expected to reach $2.886 billion by 2018, growing at a CAGR of 11.5% during the forecast period. The report on the market for global apheresis devices analyzes the market by three main segments: applications, procedures, and technologies. Geographically, the market is mainly segmented into North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW). The report also provides an extensive competitive landscape of companies operating in this market. |
Upcoming |
|
|
Apheresis Disposables The report “Global Apheresis disposables Market forecast, 2008-2018 “analyzes the market of disposables by 3 main segments such as by applications, procedures, and technologies. Geographically, the market is mainly segmented into North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
Plasmapheresis Plasmapheresis and Plateletpheresis, Erythrocytapheresis and... |
Upcoming |
|
|
Plateletpheresis Plateletpheresis and Plasmapheresis, Erythrocytapheresis and |
Upcoming |
|
|
Erythrocytapheresis Erythrocytapheresis and Plasmapheresis, Plateletpheresis and |
Upcoming |
|
|
Leukapheresis Leukapheresis and Plasmapheresis, Plateletpheresis and |
Upcoming |
|
|
Asian Apheresis Devices The Asian market for apheresis devices is mainly driven by increasing prevalence of blood disorders such as bleeding problems and platelet disorders. The report analyzes the market under segments such as applications, procedures, and technologies. Geographically, the market is mainly segmented into China, Japan, India, and Rest of Asia-Pacific. The report also provides an extensive competitive landscape of companies operating in this market. |
Upcoming |
|
|
European Apheresis Devices The European market for apheresis devices is mainly driven by increasing prevalence of blood disorders such as bleeding problems and platelet disorders. The report analyzes the market under segments such as applications, procedures, and technologies. Geographically, the market is segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report also provides an extensive competitive landscape of companies operating in this market. |
Upcoming |
|
|
North American Apheresis Devices The North American market for apheresis devices is mainly driven by increasing prevalence of blood disorders such as bleeding problems and platelet disorders. The report analyzes the market under segments such as applications, procedures, and technologies. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report also provides an extensive competitive landscape of companies operating in this market. |
Upcoming |
|
|
Asian Apheresis Disposables The Asian market for apheresis disposables, mainly driven by increasing prevalence of blood disorders such as bleeding problems and platelet disorders, is expected to grow substantially during the forecast period (2013-2018). The report on this market analyzes it under three main segments: applications, procedures, and technologies. Geographically, the market is mainly segmented into Japan, China, India, and Rest of Asia-Pacific (APAC). The report also provides an extensive competitive landscape of companies operating in this market. |
Upcoming |
|
|
European Apheresis Disposables The European market for apheresis disposables, mainly driven by increasing prevalence of blood disorders such as bleeding problems and platelet disorders, is expected to grow substantially during the forecast period (2013-2018). The report on this market analyzes it under three main segments: applications, procedures, and technologies. Geographically, the market is mainly segmented into U.K., Germany, France, Italy, Spain, and Rest of Europe. The report also provides an extensive competitive landscape of companies operating in this market. |
Upcoming |
|
|
North American Apheresis Disposables The North American Apheresis disposables Market, mainly driven by increasing prevalence of blood disorders such as bleeding problem and platelet disorder are expected to drive market growth during the forecast period. In addition, growing prevalence of chronic diseases such as cancer or autoimmune diseases, supply of platelets owing to an increasing number of platelet donors, improvement in healthcare infrastructure and facilities and demand for plasma by biopharmaceutical companies. The report “North American Apheresis disposables Market forecast, 2008-2018 “analyzes the market of disposables by 3 main segments such as by applications, procedures, and technologies. Geographically, the market is mainly segmented into U.S., Canada, and Mexico. The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
North American Apheresis Market The North American Apheresis market was valued at $641.71 million in 2013 and is expected to reach $1062.59 million by 2018 growing at a CAGR of 10.6% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
|
|
European Apheresis Market The European Apheresis market was valued at $6366.89 million in 2013 and is expected to reach $596.13 million by 2018 growing at a CAGR of 10.2% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
|
|
Asian Apheresis Market The Asian Apheresis market was valued at $353.79 million in 2013 and is expected to reach $467.59 million by 2018 growing at a CAGR of 13.0% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
